drugset / Trial / NCT04432155

Xenon Inhalation for Treatment of Panic Disorder

NCT04432155

Phase 2/3 Unknown 200 enrolled Nobilis Therapeutics Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with panic disorder.

Timeline

Start
2021-06
Primary completion
2021-11
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenon Other / unclassified 10 unknown Inhaled

Indications